Breast cancer among the oldest old: Tumor characteristics, treatment choices, and survival

Journal of Clinical Oncology

Volumn 28, Issue 12, 2010, Pages 2038-2045

  Schonberg, Mara A ^a   Marcantonio, Edward R ^a   Li, Donglin ^a   Silliman, Rebecca A ^a   Ngo, Long ^a   McCarthy, Ellen P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER SURVIVAL; COMORBIDITY; CONTROLLED STUDY; FEMALE; GERIATRICS; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PRIORITY JOURNAL; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; AGE; BREAST TUMOR; CANCER REGISTRY; CANCER STAGING; CLINICAL PRACTICE; COMPARATIVE STUDY; ELDERLY CARE; HEALTH CARE DISPARITY; MORTALITY; PATHOLOGY; PATIENT SELECTION; PROPORTIONAL HAZARDS MODEL; REGISTER; RISK ASSESSMENT; RISK FACTOR; SEGMENTAL MASTECTOMY; STATISTICAL MODEL; STATISTICS; TIME; TREATMENT OUTCOME; UNITED STATES; UTILIZATION REVIEW;

ANTINEOPLASTIC AGENT;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMORBIDITY; FEMALE; HEALTH SERVICES FOR THE AGED; HEALTHCARE DISPARITIES; HUMANS; LOGISTIC MODELS; MASTECTOMY; MASTECTOMY, SEGMENTAL; NEOPLASM STAGING; PATIENT SELECTION; PHYSICIAN'S PRACTICE PATTERNS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEER PROGRAM; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 77951641141     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.25.9796     Document Type: Article

References (35)

1. Breast Cancer Facts and Figures 2007-2008. http://www.cancer.org/ downloads/stt/bcff-final.pdf
2. Bouchardy C, Rapiti E, Fioretta G, et al: Undertreatment strongly decreases prognosis of breast cancer in elderly women. J Clin Oncol 21:3580-3587, 2003 (Pubitemid 46594049)
3. Gajdos C, Tartter PI, Bleiweiss IJ, et al: The consequence of undertreating breast cancer in the elderly. J Am Coll Surg 192:698-707, 2001 (Pubitemid 32506497)
4. Hébert-Croteau N, Brisson J, Latreille J, et al: Compliance with consensus recommendations for the treatment of early stage breast carcinoma in elderly women. Cancer 85:1104-1113, 1999 (Pubitemid 29115590)
5. Du X, Goodwin JS: Increase of chemotherapy use in older women with breast carcinoma from 1991 to 1996. Cancer 92:730-737, 2001
6. Elkin EB, Hurria A, Mitra N, et al: Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: Assessing outcome in a population-based, observational cohort. J Clin Oncol 24:2757-2764, 2006 (Pubitemid 46630573)
7. Giordano SH, Duan Z, Kuo YF, et al: Use and outcomes of adjuvant chemotherapy in older women with breast cancer. J Clin Oncol 24:2750-2756, 2006 (Pubitemid 46630572)
8. Smith BD, Gross CP, Smith GL, et al: Effectiveness of radiation therapy for older women with early breast cancer. J Natl Cancer Inst 98:681-690, 2006 (Pubitemid 43821786)
9. Mandelblatt JS, Hadley J, Kerner JF, et al: Patterns of breast carcinoma treatment in older women: Patient preference and clinical and physical influences. Cancer 89:561-573, 2000 (Pubitemid 30642535)
10. Ballard-Barbash R, Potosky AL, Harlan LC, et al: Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst 88:716-726, 1996 (Pubitemid 26195019)
11. Enger SM, Thwin SS, Buist DS, et al: Breast cancer treatment of older women in integrated health care settings. J Clin Oncol 24:4377-4383, 2006 (Pubitemid 46630974)
12. Litvak DA, Arora R: Treatment of elderly breast cancer patients in a community hospital setting. Arch Surg 141:985-990, 2006 (Pubitemid 44583254)
13. Giordano SH, Hortobagyi GN, Kau SW, et al: Breast cancer treatment guidelines in older women. J Clin Oncol 23:783-791, 2005 (Pubitemid 46224177)
14. Gazetas P, Estabrook A, O'Neil J, et al: Importance of adequate staging and of hormone receptors in women older than age 70 with breast cancer. Ann Surg 216:22-26, 1992
15. Owusu C, Lash TL, Silliman RA: Effect of undertreatment on the disparity in age-related breast cancer-specific survival among older women. Breast Cancer Res Treat 102:227-236, 2007 (Pubitemid 46452169)
16. Yood MU, Owusu C, Buist DS, et al: Mortality impact of less-than-standard therapy in older breast cancer patients. J Am Coll Surg 206:66-75, 2008 (Pubitemid 350267255)
17. National Cancer Institute: Procedure Codes for SEER-Medicare Analyses. http://healthservices .cancer.gov/seermedicare/considerations/procedure-codes. html
18. Ries LAG, Kosary CL, Hankey BF, et al: SEER Cancer Statistics Review, 1973-1994. National Cancer Institute. NIH Publication No. 97-2789. Bethesda, MD, 1997
19. Warren JL, Harlan LC, Fahey A, et al: Utility of the SEER-Medicare data to identify chemotherapy use. Med Care 40:IV-55-61, 2002 (suppl 8)
20. Bach PB, Guadagnoli E, Schrag D, et al: Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Med Care 40:IV-19-25, 2002 (suppl 8)
21. National Cancer Institute: SEER-Medicare: Calculation of Comorbidity Weights. http://healthservices .cancer.gov/seermedicare/program/comorbidity.html
22. NCCN Clinical Practice Guidelines in Oncology. Breast Cancer. V.I. 2009. http://www.nccn.org/ professionals/physician-gls/PDF/breast.pdf
23. Giordano SH, Kuo YF, Duan Z, et al: Limits of observational data in determining outcomes from cancer therapy. Cancer 112:2456-2466, 2008
24. Parsons LS: Reducing bias in a propensity score matched-pair sample using greedy matching techniques. SUGI 26. http://www2.sas.com/proceedings/sugi26/ p214-26.pdf
25. Diab SG, Elledge RM, Clark GM: Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 92:550-556, 2000 (Pubitemid 30212316)
26. Fernö M, Borg A, Johansson U, et al: Estrogen and progesterone receptor analyses in more than 4,000 human breast cancer samples: A study with special reference to age at diagnosis and stability of analyses - Southern Swedish Breast Cancer Study Group. Acta Oncol 29:129-135, 1990 (Pubitemid 20145272)
27. Wildiers H, Van Calster B, van de Poll-Franse LV, et al: Relationship between age and axillary lymph node involvement in women with breast cancer. J Clin Oncol 27:2931-2937, 2009
28. Hughes KS, Schnaper LA, Berry D, et al: Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 351:971-977, 2004 (Pubitemid 39166260)
29. Fyles AW, McCready DR, Manchul LA, et al: Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med 351:963-970, 2004
30. Silliman RA, Guadagnoli E, Rakowski W, et al: Adjuvant tamoxifen prescription in women 65 years and older with primary breast cancer. J Clin Oncol 20:2680-2688, 2002 (Pubitemid 34575641)
31. Owusu C, Lash TL, Silliman RA: Effectiveness of adjuvant tamoxifen therapy among older women with early stage breast cancer. Breast J 13:374-382, 2007 (Pubitemid 46985564)
32. Lin DY, Psaty BM, Kronmal RA: Assessing the sensitivity of regression results to unmeasured confounders in observational studies. Biometrics 54:948-963, 1998 (Pubitemid 28429289)
33. Mitra N, Heitjan DF: Sensitivity of the hazard ratio to nonignorable treatment assignment in an observational study. Stat Med 26:1398-1414, 2007 (Pubitemid 46380849)
34. Kircher T, Nelson J, Burdo H: The autopsy as a measure of accuracy of the death certificate. N Engl J Med 313:1263-1269, 1985 (Pubitemid 16217049)
35. Mollo F, Berry DA, Cirrincione CT, et al: Reliability of death certifications for different types of cancer. An autopsy survey. Pathol Res Pract 181:442-447, 1986 (Pubitemid 16007642)